Ann L. Walker

1.4k total citations
15 papers, 528 citations indexed

About

Ann L. Walker is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Ann L. Walker has authored 15 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Genetics. Recurrent topics in Ann L. Walker's work include Melanoma and MAPK Pathways (5 papers), Synthesis of Tetrazole Derivatives (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Ann L. Walker is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Synthesis of Tetrazole Derivatives (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Ann L. Walker collaborates with scholars based in United Kingdom, France and Ireland. Ann L. Walker's co-authors include Katherine L. Jones, Paul Bamborough, Richard Angell, Stuart Cockerill, Scott H. Dickerson, Robert A. Mook, Karen Lackey, Edgar R. Wood, Kimberly G. Petrov and David W. Rusnak and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and Soil Science Society of America Journal.

In The Last Decade

Ann L. Walker

15 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann L. Walker United Kingdom	10	232	208	92	90	38	15	528
Yingjun Li China	19	382 1.6×	168 0.8×	113 1.2×	48 0.5×	9 0.2×	58	971
Yuanyuan Zhang China	21	705 3.0×	167 0.8×	104 1.1×	30 0.3×	10 0.3×	83	1.2k
Jinlian Wang China	15	421 1.8×	121 0.6×	77 0.8×	26 0.3×	2 0.1×	36	878
Chon‐Kit Chou Taiwan	14	244 1.1×	120 0.6×	107 1.2×	15 0.2×	3 0.1×	31	608
Baolin Li China	13	216 0.9×	252 1.2×	45 0.5×	8 0.1×	7 0.2×	41	530
Chunling Guo China	9	131 0.6×	45 0.2×	25 0.3×	20 0.2×	8 0.2×	21	307
Yingying Ran China	11	155 0.7×	108 0.5×	18 0.2×	39 0.4×	11 0.3×	24	390
Edward C. Smith United States	15	509 2.2×	357 1.7×	146 1.6×	27 0.3×	13 0.3×	31	972
Punnajit Lim United States	11	158 0.7×	69 0.3×	62 0.7×	8 0.1×	3 0.1×	14	523
Chunqi Hu China	14	200 0.9×	254 1.2×	94 1.0×	47 0.5×		38	590

Countries citing papers authored by Ann L. Walker

Since Specialization

Citations

This map shows the geographic impact of Ann L. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann L. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann L. Walker more than expected).

Fields of papers citing papers by Ann L. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann L. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann L. Walker. The network helps show where Ann L. Walker may publish in the future.

Co-authorship network of co-authors of Ann L. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Ann L. Walker. A scholar is included among the top collaborators of Ann L. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann L. Walker. Ann L. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Walker, Ann L., Ryan P. Bingham, Duncan S. Holmes, et al.. (2019). Structure guided drug design to develop kallikrein 5 inhibitors to treat Netherton syndrome. Bioorganic & Medicinal Chemistry Letters. 29(12). 1454–1458. 6 indexed citations

Thorpe, James H., Kathrine J. Smith, Xiao Qing Lewell, et al.. (2019). Evaluation of a crystallographic surrogate for kallikrein 5 in the discovery of novel inhibitors for Netherton syndrome. Acta Crystallographica Section F Structural Biology Communications. 75(5). 385–391. 2 indexed citations

Walker, Ann L., Alexis Denis, Ryan P. Bingham, et al.. (2019). Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(20). 126675–126675. 6 indexed citations

White, Gemma V., Duncan S. Holmes, Xiao Qing Lewell, et al.. (2019). Kallikrein 5 inhibitors identified through structure based drug design in search for a treatment for Netherton Syndrome. Bioorganic & Medicinal Chemistry Letters. 29(6). 821–825. 8 indexed citations

Hutchinson, Jonathan P., Paul Rowland, Carl Haslam, et al.. (2017). Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase. Nature Communications. 8(1). 15827–15827. 37 indexed citations

Liddle, John, Margaret Binnie, Anne Bouillot, et al.. (2017). The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis. Bioorganic & Medicinal Chemistry Letters. 27(9). 2023–2028. 9 indexed citations

Bamborough, Paul, Duncan S. Holmes, Katherine L. Jones, et al.. (2009). p38α Mitogen-Activated Protein Kinase Inhibitors: Optimization of a Series of Biphenylamides to Give a Molecule Suitable for Clinical Progression. Journal of Medicinal Chemistry. 52(20). 6257–6269. 35 indexed citations

Angell, Richard, Paul Bamborough, Jacky B. Buckton, et al.. (2008). Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity. Bioorganic & Medicinal Chemistry Letters. 18(15). 4428–4432. 63 indexed citations

Angell, Richard, Paul Bamborough, Mark J. Bamford, et al.. (2008). Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes. Bioorganic & Medicinal Chemistry Letters. 18(15). 4433–4437. 52 indexed citations

10.

Angell, Richard, Paul Bamborough, Anne Cleasby, et al.. (2007). Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode. Bioorganic & Medicinal Chemistry Letters. 18(1). 318–323. 32 indexed citations

11.

Angell, Richard, Paul Bamborough, David Brown, et al.. (2007). Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR. Bioorganic & Medicinal Chemistry Letters. 18(1). 324–328. 24 indexed citations

12.

Petrov, Kimberly G., Yuemei Zhang, G. Stuart Cockerill, et al.. (2006). Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series. Bioorganic & Medicinal Chemistry Letters. 16(17). 4686–4691. 144 indexed citations

13.

Giblin, Gerard M.P., Ian B. Campbell, Ashley P. Hancock, et al.. (2001). 6,6′-Bis(2-hydroxyphenyl)-2,2′-bipyridine manganese(III) complexes: A novel series of superoxide dismutase and catalase mimetics. Bioorganic & Medicinal Chemistry Letters. 11(11). 1367–1370. 26 indexed citations

14.

Walker, Ann L.. (1983). The Effects of Magnetite on Oxalate‐ and Dithionite‐Extractable Iron. Soil Science Society of America Journal. 47(5). 1022–1026. 75 indexed citations

15.

Clegg, K. Mary, et al.. (1974). Production of an enzymic hydrolysate of casein on a kilogram scale. International Journal of Food Science & Technology. 9(4). 425–431. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact